On September 18, X-Energy fell 5.17% in regular trading, trading at $15.49/share, with turnover of $26.82 million. The stock gave back gains from the prior session's 7.1% rally to $16.19, which had been driven by positive developments surrounding its UK nuclear project.
On the news front, X-Energy and British energy giant Centrica recently had their Xe-100 small modular reactor accepted by UK regulators into the generic design assessment process, with the technical, safety, and environmental evaluation expected to span roughly three years. The joint venture aims to construct up to 6 gigawatts of new nuclear capacity across 10 to 20 British power stations. However, the stock's pattern mirrors a similar episode on September 14, when a 7.64% rebound was followed by a 5.02% decline the next day.
Adding sustained pressure, Piper Sandler recently initiated coverage of X-Energy with an underweight rating and a $9 price target, sharply below the analyst consensus target of $34.38. On the fundamental side, Q2 revenue of $54.6 million beat expectations, but the adjusted per-share loss of $0.15 fell short of estimates.
X-Energy develops advanced small modular reactor technology and manufactures nuclear fuel, serving utility and industrial customers amid growing power demand driven by artificial intelligence and data center expansion.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)
Comments